Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Allarity Therapeutics, Inc. (ALLR) has provided an announcement.
Allarity Therapeutics, Inc. streamlined its capital structure by converting all outstanding Series A Preferred Stock into common stock and converting 93% of its warrants, leaving only a few unexercised. The company also announced the full repayment of all bridge notes, including principal and interest, marking a significant financial restructuring aimed at simplifying the company’s share classification and reducing debt.
See more data about ALLR stock on TipRanks’ Stock Analysis page.